II. Definitions
- Chronic Daily Headache
- Headache on at least 15 days/month AND for at least 3 months
III. Epidemiology
-
Incidence
- Chronic Daily Headache accounts for 3-5% of acute Headache presentations in U.S.
- Race
- More common in white patients by a factor of 1.3
- Gender
- More common in women (5-9% Prevalence) than men (1-3% Prevalence)
-
Prevalence
- Headaches >15 days/month: 5% of U.S. population
- Migraine Headaches: 25% of the U.S. population
- References
IV. Differential Diagnosis: Short Duration Chronic Daily Headache
- Brief Headache syndrome
- Hypnic Headache
- Headache onset with sleep
- Primary Cough Headache
- Primary Exertional Headache
- Primary Stabbing Headache
- Hypnic Headache
- Trigeminal autonomic Cephalgia (cluster-like, shorter duration)
- Chronic Cluster Headache
- Paroxysmal Hemicrania
- SUNA/SUNCT
V. Differential Diagnosis: Long Duration Chronic Daily Headache
- Common Primary Headaches
- Tension Headache
- Migraine Tension-Type Headache complex
- Features of both Tension Headache and Migraine Headache may may characterization and medication selection difficult
- Often evolves from Migraine Headache
- Migraine Headache (<3 days duration)
- Under-recognized (may account for 95% of acute Headache presentations to ED)
- Transformed Migraine
- Responsible for many Migraine Headache patients presenting with Chronic Daily Headache
- Represents Chronic Daily Headache with periodic Migraine Headache flares of worsening
- Less common Headaches
- Hemicrania Continua
- Trigeminal autonomic Cephalgia (cluster-like, longer duration)
- New Daily Persistent Headache
- Features similar to Migraine or Tension Headache, but becomes constant and unremitting in the first 3 days
- Hemicrania Continua
VI. Differential Diagnosis: Secondary Headaches
- See Headache Red Flags
- See Chronic Progressive Headaches (Organic Headache)
-
Analgesic or Ergotamine Rebound Headache
- Almost two thirds of Chronic Daily Headache patients have used Analgesics on 14 or more days per month
- Wiendels (2006) Cephalalgia 26(12): 1434-42 [PubMed]
- Myofacial pain
- Cervical Spine disorder
- Temperomandibular joint dysfunction
- Obstructive Sleep Apnea
VII. History
- See Headache History
VIII. Exam
IX. Imaging
- Indications
- See Headache Red Flags
- Cases in which diagnostic testing can be avoided
- No Headache Red Flags suggesting Organic Headache
- Stable Headache pattern for >6 months
- No associated neurologic changes
- Imaging modality options
X. Management: Non-pharmacologic
-
General measures (minimal evidence)
- Sleep Hygiene
- Avoid Caffeine
- Avoid Tobacco
- Maintain hydration and nutritional intake
- Physical rehabilitation interventions
- Cervical neck Exercises (low load)
- Osteopathic cervical manipulation
- Acupuncture (for Tension Headaches)
- Occipital region Peripheral Nerve stimulation
- Psychological interventions
XI. Management: Pharmacologic
- Reduce or eliminate Headache abortive Analgesics
- See Analgesic Rebound Headache
- Analgesic overuse is a common contributing factor to Chronic Daily Headache
- Limit Analgesics to less than one third the days of the month
- Some Headache experts recommend complete Analgesic withdrawal in Chronic Daily Headache
- Some studies suggest partial Analgesic withdrawal on Headache prophylaxis is effective
- Hagen (2011) Acta Neurol Scand Suppl (191): 38-43 [PubMed]
-
Headache prophylaxis agents for Chronic Daily Headache from Tension Headache or Migraine Headache
- Tricyclic Antidepressants (e.g. Amitriptyline, Nortriptyline)
- Effective for Migraine Headache and Tension Headache prevention
- Couch (2011) Headache 51(1): 33-51 [PubMed]
- Tizanidine (Zanaflex)
- Saper (2002) Headache 42(6): 470-82
- Gabapentin (Neurontin)
- Tricyclic Antidepressants (e.g. Amitriptyline, Nortriptyline)
-
Headache prophylaxis for chronic Migraine Headache
- See Migraine Prophylaxis
- See agents listed above (TCA, Tizanidine, Gabapentin)
- Propranolol
- Valproate
- Topiramate (Topamax)
- Onabotulinumtoxin A local injection
- Avoid ineffective agents for Headache prophylaxis
- Selective Serotonin Reuptake Inhibitors (SSRI) such as Fluoxetine (Prozac)
- Not found to be effective in Headache prophylaxis
- Moja (2005) Cochrane Database Syst Rev (3): CD02919 [PubMed]
- Selective Serotonin Reuptake Inhibitors (SSRI) such as Fluoxetine (Prozac)